Clinical Trial Update: Peking and Rotterdam on Mission to Reduce Coronary Artery Disease [NA]

View source ↗

Summary

An international clinical trial collaboration between Peking University Third Hospital and Rotterdam aims to reduce coronary artery disease, with focus on Acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Diabetes Mellitus

Snippet

Sponsor: Peking University Third Hospital | Conditions: Acute Coronary Syndrome, Diabetes Mellitus | NA | Status: UNKNOWN